Background Uptake of treatment for hepatitis C virus (HCV) is low in Canada despite its
publicly funded health care system. We explored the uptake of HCV treatment within the …

Objectives The factors associated with hepatitis C virus (HCV) treatment uptake and
responses were assessed among HCV/HIV co-infected individuals referred for HCV therapy …

Objectives Little is known about the cascade of hepatitis C care among HIV/hepatitis C virus
(HCV)-coinfected patients in community-based clinics. Thus, we analysed our data from the …

Liver disease due to hepatitis C virus (HCV) infection is a leading cause of non‐AIDS‐
related morbidity and mortality in patients infected with HIV. We assessed the frequency of …

Hepatitis C virus (HCV) is a major cause of liver disease in HIV-infected patients. The HCV
treatment outcomes and barriers to HCV referral were examined in a centre with a HIV/HCV …

Abstract Treatment rates for hepatitis C virus (HCV) are low in actual clinical settings.
However, the proportion of patients eligible for treatment, especially among those coinfected …

Background The aims were to investigate the hepatitis C (HCV) cascade of care among HIV-
infected patients and to identify reasons for not referring for and not initiating HCV therapy …

Objective: To evaluate predictors and trends of referral for hepatitis C virus (HCV) care, clinic
attendance and treatment in an urban HIV clinic. Design and methods: A retrospective …

Uptake of hepatitis C (HCV) treatment in HIV-coinfected patients is not well described. Of
2356 HCV-seropositive patients, 180 (7.6%) started HCV treatment with interferon-based …

Objective Half of the people living with HIV (PLWH) with hepatitis C virus (HCV) remain
untreated for HCV. We examined predictors of HCV linkage to care among PLWH and the …